Latest Life In Science
An Interview With CRISPR Pioneer Jennifer A. Doudna
In this interview, award-winning scientist Jennifer A. Doudna PhD – renowned for her fundamental work and leadership in developing CRISPR-mediated genome editing – touches on her current research focus, her greatest professional achievements and discusses what can be done to encourage more women to get involved in science.READ MORE
Addressing Real-world Challenges With Technology: An Interview With Christie Hunter Ph.D.
Christie Hunter is the Director of Applications at SCIEX where her and her team are tasked with developing new applications for SCIEX products, from screening for pesticides in our food supply through to molding the way cancer biomarkers are found. We spoke to Christie about her career, achievements and challenges for the future.READ MORE
Developing FTICR Mass Spectrometry Instruments with Unique Capabilities
Here Prof. Peter B. O'Connor, University of Warwick, touches on the adaptability of mass spectrometry, enabling researchers to study cancer, neurological disease, petroleum, and biopharmaceuticals.READ MORE
Novel Technology Unlocks the Power of Positron Emission Tomography, Improving Disease Diagnostics
We recently spoke to Anton Toutov, Co-Founder and CSO at Fuzionaire, to learn how their radiolabeling platform can be used to improve disease diagnoses and drug discovery efforts. Anton touches on his professional background, his research on catalysis at Caltech, and how the discovery of a fundamentally new way to make and break molecular bonds can be applied to the diagnostics field.READ MORE
Transforming Drug Discovery by Accelerating the Development of More Effective Therapies
John Baldoni currently heads up a drug discovery unit at GlaxoSmithKline. Since joining GSK in 1989, John has held numerous positions within the company and
has led many significant cross-functional strategic initiatives. The recently established Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, was conceived by John, with a mission “to accelerate the development of more effective therapies for patients”
Liquid Biopsy as an Alternative to Traditional Tissue Biopsy
Since co-founding Vortex Biosciences in 2012, Elodie Sollier-Christen, PhD has continued to be recognized for her work within the field of microfluidics, her expertise focused on the development of microfluidic devices for biological applications. Her determination to make a difference to the field of cancer diagnostics has driven her to successfully transform a microfluidic research platform in to a commercial product for liquid biopsy.READ MORE
From the lab to the boardroom: An interview with Darlene Solomon Ph.D.
We spoke to Darlene to learn about her reasons for studying science, how she transitioned away from the lab and some of her proudest achievements at Agilent.READ MORE